{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:15:58Z","timestamp":1791332158366,"version":"4.3.1"},"reference-count":25,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2014,10,2]],"date-time":"2014-10-02T00:00:00Z","timestamp":1412208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Medical Research Foundation for Mothers and Babies"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2015,4]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Thyroid peroxidase antibodies (<jats:styled-content style=\"fixed-case\">TPOA<\/jats:styled-content>b) and thyroglobulin antibodies (<jats:styled-content style=\"fixed-case\">TGA<\/jats:styled-content>b) are frequently measured to investigate thyroid dysfunction in pregnancy. Despite the recognized fall of these autoantibodies in pregnancy, there is limited guidance on the timing of such testing. We assessed optimal test timing of <jats:styled-content style=\"fixed-case\">TPOA<\/jats:styled-content>b\/<jats:styled-content style=\"fixed-case\">TGA<\/jats:styled-content>b for the detection of Hashimoto's thyroiditis and post\u2010partum thyroid dysfunction (<jats:styled-content style=\"fixed-case\">PPTD<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Prospective longitudinal study with recruitment in Trimester 1.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients<\/jats:title><jats:p>Healthy women \u226413\u00a0weeks' gestation from Mercy Hospital for Women, a tertiary obstetric hospital in Melbourne.<\/jats:p><\/jats:sec><jats:sec><jats:title>Measurements<\/jats:title><jats:p>Serum TPOAb, TGAb, TSH and <jats:styled-content style=\"fixed-case\">fT<\/jats:styled-content>4 were measured at Trimester 1 (T1), Trimester 2(T2), Trimester 3(T3) and postpartum (PP) in each participant. Post\u2010partum thyroid dysfunction (PPTD) was defined if TSH deviated from the assay's nonpregnant reference interval. Longitudinal random\u2010effect logistic regression was used to investigate the association between time and positive\/negative thyroid autoantibody status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Samples from 140 women at T1 (12\u00b70: 10\u00b73\u201313\u00b70) (median: <jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content> weeks' gestation); 95 at T2 (24\u00b73: 23\u00b70\u201325\u00b79), 79 at T3 (35\u00b79: 34\u00b78\u201336\u00b77) and 83 at <jats:styled-content style=\"fixed-case\">PP<\/jats:styled-content> (12\u00b74: 10\u00b78\u201314\u00b76\u00a0weeks post\u2010partum) were attained. At T1, 13 (9%) and 15 (11%) women had positive <jats:styled-content style=\"fixed-case\">TPOA<\/jats:styled-content>b and <jats:styled-content style=\"fixed-case\">TGA<\/jats:styled-content>b, respectively. The odds of having a positive <jats:styled-content style=\"fixed-case\">TPOA<\/jats:styled-content>b were 96% lower at T2 [<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\u00a0=\u00a00\u00b704 (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0\u00b702\u20130\u00b78; <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0\u00b703)] and 97% lower at T3 [<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\u00a0=\u00a00\u00b703 (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0\u00b7001\u20130\u00b76; <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0\u00b702)] than at T1. Similarly, the odds of having a positive <jats:styled-content style=\"fixed-case\">TGA<\/jats:styled-content>b were 99\u00b74% lower [<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\u00a0=\u00a00\u00b7006 (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0\u20130\u00b73; <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0\u00b701)] at T2, and 99\u00b75% lower [<jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\u00a0=\u00a00\u00b7005 (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0\u20130\u00b74; <jats:italic>P\u00a0<\/jats:italic>=<jats:italic>\u00a0<\/jats:italic>0\u00b702)] at T3 than at T1. The <jats:styled-content style=\"fixed-case\">ROC<\/jats:styled-content> analysis diagnostic <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>s for a positive <jats:styled-content style=\"fixed-case\">TPOA<\/jats:styled-content>b and\/or <jats:styled-content style=\"fixed-case\">TGA<\/jats:styled-content>b to predict <jats:styled-content style=\"fixed-case\">PPTD<\/jats:styled-content> were 7\u00b78 (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 2\u00b72\u201327\u00b76), 1\u00b72 (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0\u20138\u00b79), 2\u00b70 (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 0\u201316\u00b78), and 12\u00b72 (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: 3\u00b73\u201344\u00b79) at T1, T2, T3 and post\u2010partum, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A significant proportion of pregnant women lose their thyroid autoantibody positivity after T1. The gestation\u2010dependent loss of <jats:styled-content style=\"fixed-case\">TPOA<\/jats:styled-content>b\/<jats:styled-content style=\"fixed-case\">TGA<\/jats:styled-content>b positivity and reduction in diagnostic accuracy for predicting <jats:styled-content style=\"fixed-case\">PPTD<\/jats:styled-content> limits the value of testing at T2 and T3.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cen.12571","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T15:54:02Z","timestamp":1406735642000},"page":"604-610","source":"Crossref","is-referenced-by-count":33,"title":["A longitudinal study of thyroid autoantibodies in pregnancy: the importance of test timing"],"prefix":"10.1111","volume":"82","author":[{"given":"E.I.","family":"Ekinci","sequence":"first","affiliation":[{"name":"Department of Endocrinology Austin Health Melbourne Vic. Australia"},{"name":"Department of Medicine University of Melbourne Melbourne Vic. Australia"},{"name":"Menzies School of Health Research Darwin NT Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.\u2010L.","family":"Chiu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology Austin Health Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.X.","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology Melbourne Pathology Melbourne Vic. Australia"},{"name":"Department of Medicine Monash University Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sikaris","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology Melbourne Pathology Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Churilov","sequence":"additional","affiliation":[{"name":"Florey Institute of Neuroscience and Mental Health Melbourne Vic. Australia"},{"name":"School of Mathematical and Geospatial Sciences RMIT University Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Bittar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry Austin Health Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Biochemistry Austin Health Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Crinis","sequence":"additional","affiliation":[{"name":"Department of Biochemistry Austin Health Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"Houlihan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology Austin Health Melbourne Vic. Australia"},{"name":"Mercy Hospital for Women Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,10,2]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2004.tb05866.x"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8182"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03450110068029"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.1.197"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldq039"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2004.03.001"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1603"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0340"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1089\/105072502753451986"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908193410801"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/jms.8.1.18"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2005.15.474"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1390036"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-21-7-792"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2011.0087"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2803"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004563213486450"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1586\/eci.11.42"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/182472"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.74.3.645"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.2056"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.22.5.0441"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00807.x"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1529-1049(00)00008-8"},{"key":"e_1_2_9_26_1","first-page":"30","article-title":"Changes of serum anti\u2010thyroid antibodies during and after pregnancy in autoimmune thyroid diseases","volume":"31","author":"Amino N.","year":"1978","journal-title":"Clinical and Experimental Immunology"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcen.12571","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.12571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T08:56:27Z","timestamp":1695545787000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cen.12571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,2]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1111\/cen.12571"],"URL":"https:\/\/doi.org\/10.1111\/cen.12571","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,2]]}}}